Nodai Akiko, Machida Takuji, Izumi Sachiko, Hamaya Yumika, Kohno Takayuki, Igarashi Yasuyuki, Iizuka Kenji, Minami Masaru, Hirafuji Masahiko
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Hokkaido 061-0293, Japan.
Life Sci. 2007 Apr 17;80(19):1768-76. doi: 10.1016/j.lfs.2007.02.008. Epub 2007 Feb 20.
The effects of sphingosine 1-phosphate (S1P) on prostaglandin I(2) (PGI(2)) production and cyclooxygenase (COX) expression in cultured rat vascular smooth muscle cells (VSMCs) were investigated. S1P stimulated PGI(2) production in a concentration-dependent manner, which was completely suppressed by NS-398, a selective COX-2 inhibitor, as determined by radioimmunoassay. S1P stimulated COX-2 protein and mRNA expressions in a concentration- and time-dependent manner, while it had no effect on COX-1 expression. S1P(2) and S1P(3) receptors mRNA were abundantly expressed in rat VSMCs. Suramin, an antagonist of S1P(3) receptor, almost completely inhibited S1P-induced COX-2 expression. Pretreatment of VSMCs with pertussis toxin (PTX) partially, but significantly inhibited S1P-induced PGI(2) production and COX-2 expression. S1P also activated extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinase (MAPK). However, neither PD 98059, a selective inhibitor of ERK activation, nor SB 203580, a selective inhibitor of p38 MAPK, had a significant inhibitory effect on S1P-induced COX-2 expression, suggesting that the MAPK activation does not play main roles in S1P-induced COX-2 induction. S1P-induced COX-2 expression was inhibited by PP2, an inhibitor of Src-family tyrosine kinase, Ca(2+) depletion, and GF 109203X, an inhibitor of protein kinase C (PKC). These results suggest that S1P stimulates COX-2 induction in rat VSMCs through mechanisms involving Ca(2+)-dependent PKC and Src-family tyrosine kinase activation via S1P(3) receptor coupled to PTX-sensitive and -insensitive G proteins.
研究了1-磷酸鞘氨醇(S1P)对培养的大鼠血管平滑肌细胞(VSMC)中前列腺素I(2)(PGI(2))生成及环氧化酶(COX)表达的影响。通过放射免疫分析测定,S1P以浓度依赖的方式刺激PGI(2)生成,而这被选择性COX-2抑制剂NS-398完全抑制。S1P以浓度和时间依赖的方式刺激COX-2蛋白和mRNA表达,而对COX-1表达无影响。S1P(2)和S1P(3)受体mRNA在大鼠VSMC中大量表达。S1P(3)受体拮抗剂苏拉明几乎完全抑制S1P诱导的COX-2表达。用百日咳毒素(PTX)预处理VSMC可部分但显著抑制S1P诱导的PGI(2)生成和COX-2表达。S1P还激活细胞外信号调节激酶(ERK)和p38丝裂原活化蛋白激酶(MAPK)。然而,ERK激活的选择性抑制剂PD 98059和p38 MAPK的选择性抑制剂SB 203580对S1P诱导的COX-2表达均无显著抑制作用,这表明MAPK激活在S1P诱导的COX-2诱导中不发挥主要作用。S1P诱导的COX-2表达被Src家族酪氨酸激酶抑制剂PP2、Ca(2+)耗竭以及蛋白激酶C(PKC)抑制剂GF 109203X抑制。这些结果表明,S1P通过涉及Ca(2+)依赖性PKC和Src家族酪氨酸激酶激活的机制,经由与PTX敏感和不敏感G蛋白偶联的S1P(3)受体刺激大鼠VSMC中COX-2的诱导。